UCB Standardizes Global Pharmacovigilance on Veeva Safety Suite
Event summary
- UCB is unifying its global safety operations on Veeva Safety Suite to streamline case processing and submissions to health authorities.
- The platform will enable automation for low-touch case processing and advanced data analysis for reporting.
- UCB aims to create a single source of truth for safety data across its global operations.
- Veeva Safety Suite includes modules for adverse event management, safety content management, and automated signal detection.
The big picture
UCB's adoption of Veeva Safety Suite reflects a broader industry trend toward digital transformation in pharmacovigilance, driven by the need for operational efficiency and regulatory compliance. The move underscores the growing reliance on specialized software platforms to manage complex safety data across global operations. Veeva's role as a provider of industry-specific cloud solutions positions it as a key player in the life sciences technology sector.
What we're watching
- Automation Impact
- How UCB's shift to low-touch case processing will affect operational efficiency and compliance.
- Data Integration
- Whether the unified platform will successfully eliminate data silos across UCB's global safety operations.
- Regulatory Alignment
- The pace at which Veeva Safety Suite's automated signal detection will improve UCB's regulatory submissions.
Related topics